These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22741804)

  • 41. Molecular dynamics and ligand docking of a hinge region variant of South African HIV-1 subtype C protease.
    Zondagh J; Balakrishnan V; Achilonu I; Dirr HW; Sayed Y
    J Mol Graph Model; 2018 Jun; 82():1-11. PubMed ID: 29625416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptor-independent 4D-QSAR analysis of a set of norstatine derived inhibitors of HIV-1 protease.
    Senese CL; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(4):1297-307. PubMed ID: 12870923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.
    Jadhav PK; Woerner FJ; Lam PY; Hodge CN; Eyermann CJ; Man HW; Daneker WF; Bacheler LT; Rayner MM; Meek JL; Erickson-Viitanen S; Jackson DA; Calabrese JC; Schadt M; Chang CH
    J Med Chem; 1998 Apr; 41(9):1446-55. PubMed ID: 9554878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A priori molecular descriptors in QSAR: a case of HIV-1 protease inhibitors. I. The chemometric approach.
    Kiralj R; Ferreira MM
    J Mol Graph Model; 2003 Mar; 21(5):435-48. PubMed ID: 12543139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational studies on HIV-1 protease inhibitors: influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models.
    Jayatilleke PR; Nair AC; Zauhar R; Welsh WJ
    J Med Chem; 2000 Nov; 43(23):4446-51. PubMed ID: 11087569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculations.
    Tzoupis H; Leonis G; Durdagi S; Mouchlis V; Mavromoustakos T; Papadopoulos MG
    J Comput Aided Mol Des; 2011 Oct; 25(10):959-76. PubMed ID: 21969102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors.
    La Monica G; Lauria A; Bono A; Martorana A
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design of tight-binding human immunodeficiency virus type 1 protease inhibitors.
    Vacca JP
    Methods Enzymol; 1994; 241():311-34. PubMed ID: 7854186
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes as C
    Li P; Wang S; Wang H; Yan H
    Biol Pharm Bull; 2019; 42(2):261-267. PubMed ID: 30713256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity.
    Wei Y; Ma CM; Hattori M
    Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design, asymmetric synthesis, and evaluation of pseudosymmetric sulfoximine inhibitors against HIV-1 protease.
    Lu D; Sham YY; Vince R
    Bioorg Med Chem; 2010 Mar; 18(5):2037-48. PubMed ID: 20138769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.
    Yan J; Huang N; Li S; Yang LM; Xing W; Zheng YT; Hu Y
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1976-9. PubMed ID: 22306123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural and energetic analysis on the complexes of clinically isolated subtype C HIV-1 proteases and approved inhibitors by molecular dynamics simulation.
    Matsuyama S; Aydan A; Ode H; Hata M; Sugiura W; Hoshino T
    J Phys Chem B; 2010 Jan; 114(1):521-30. PubMed ID: 20055526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A QSAR study of HIV protease inhibitors using theoretical descriptors.
    Basak SC; Mills D; Garg R; Bhhatarai B
    Curr Comput Aided Drug Des; 2010 Dec; 6(4):269-82. PubMed ID: 20883201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones.
    Prabhakar YS; Rawal RK; Gupta MK; Solomon VR; Katti SB
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):431-7. PubMed ID: 16101582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex.
    Ghosh AK; Brindisi M; Nyalapatla PR; Takayama J; Ella-Menye JR; Yashchuk S; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H
    Bioorg Med Chem; 2017 Oct; 25(19):5114-5127. PubMed ID: 28434781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enamino-oxindole HIV protease inhibitors.
    Eissenstat M; Guerassina T; Gulnik S; Afonina E; Silva AM; Ludtke D; Yokoe H; Yu B; Erickson J
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5078-83. PubMed ID: 22749283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.
    Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T
    SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A simple clustering technique to improve QSAR model selection and predictivity: application to a receptor independent 4D-QSAR analysis of cyclic urea derived inhibitors of HIV-1 protease.
    Senese CL; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(6):2180-93. PubMed ID: 14632470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.
    Debnath AK
    J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.